Observed the Effect of “Rong Mai San” on Anteriorischemicoptico-neuropaty Eye PRVEP

OBJECTIVE To observe the effect of “Rong Mai San” on the anteriorischemicoptico-neuropaty of the eye PRVEP. METHODS All of 58 anteriorischemicoptico-neuropaty inpatients were collected which from May 2010 to Oct 2013. Random distrubuted into two groups, including control group 30 and treatment group 28. Treatment group was administrated conventional therapy and oral “Rong Mai San”, and observed the change of PRVEP. Analysis and comparison effect of treatment in two groups. RESULTS Incubation period and amplitude of P100 no significant changes between two groups before treatment. After treatment, in control group, P100 Incubation period average, (107.40±1.45)ms，P100 Amplitude (3.34±0.11)μV; in treatment group, P100 Incubation period average (92.60±1.97)ms, P100 Amplitude (3.74±0.18)μV. Compared with two groups, the difference was statistically significant(P<0.05). Difference between the control group before and after treatment: P100 Incubation period (8.39±0.89)ms, P100 amplitude (0.22±0.02)μV, the difference before and after the treatment group: P100 Incubation period (21.95±1.30)ms, P100 amplitude (0.58±0.03)μV. Compared with two groups, the difference was statistically significant (P<0.05). CONCLUSION The eye PRVEP of anteriorischemicoptico-neuropaty is significantly improved by “Rong Mai San” treatment.